What is CliniOps?
CliniOps operates at the intersection of life sciences and digital transformation, providing a robust software ecosystem designed to optimize the clinical trial lifecycle. By prioritizing execution-first methodologies, the platform addresses critical bottlenecks in data management and trial oversight. This technological infrastructure is specifically engineered for pharmaceutical enterprises and clinical research organizations (CROs) that require high-fidelity data integrity and streamlined workflows. As the industry shifts toward decentralized and hybrid trial models, CliniOps serves as a foundational layer for organizations seeking to enhance trial efficiency and reduce time-to-market for life-saving therapies.
How much funding has CliniOps raised?
CliniOps has raised a total of $61K across 1 funding round:
Debt
$61K
Debt (2021): $61K with participation from PPP
Key Investors in CliniOps
PPP
Public-Private Partnership
What's next for CliniOps?
With the infusion of substantial expansion capital, CliniOps is poised to scale its market presence and deepen its product capabilities. The strategic focus will likely center on enhancing the platform's interoperability with existing electronic data capture systems and expanding its footprint within global clinical research markets. As the company navigates this Series B/C stage, the primary objective remains the solidification of its role as a mission-critical partner for large-scale clinical research initiatives. Future growth will likely be driven by the integration of advanced analytics and automated compliance features, ensuring that CliniOps remains at the forefront of the digital clinical trial revolution.
See full CliniOps company page
